Relative miRNA-155-5P Expression and Level of CXCL9, CXCL10 in Patients with Cutaneous leishmaniasis before and after Pentostam Treatment | ||
| Egyptian Journal of Medical Microbiology | ||
| Articles in Press, Accepted Manuscript, Available Online from 01 January 2026 | ||
| Document Type: New and original researches in the field of Microbiology. | ||
| DOI: 10.21608/ejmm.2025.402847.1771 | ||
| Authors | ||
| Lina A. Aljorany* 1; Abdul Khaliq A. Muhaimid2; Maan H. Salih2 | ||
| 1College of Dentistry, University of Diyala, Diyala, Iraq | ||
| 2Department of Biology, College of Science, Tikrit University, Tikrit, Iraq | ||
| Abstract | ||
| Background: MicroRNAs regulate several immune response pathways in patients with cutaneous leishmaniasis before and after treatment. Objective: The study aimed to estimate the level of immune response before and after treatment with Pentostam by assessing the levels of miRNA-155-5P, CXCL9, CXCL10. Methodology: This study was conducted on 60 volunteers, 30 with cutaneous leishmaniasis were tested before and after treatment and 30 as a control group. ELISA was performed to determine the level of CXCL9, CXCL10, and the gene expression of miRNA-155-5P was estimated using qRT-PCR. Results: The results of the current study showed a significant increase in relative miRNA-155-5P expression in the control group with patients before treatment (p=0.001) and after treatment(p=0.001). level of CXCL9 was significantly higher in the control group compared to the patient's two groups, p=0.001 and p=0.001, respectively. The level of CXCL10 in the control group increased significantly compared to the patient's groups before treatment (p=0.001) and after treatment (p=0.004). Conclusion: We conclude from the results of the current study that miRNA-155-5P and the immune markers; CXCL9, CXCL10, could constitute a possible therapeutic target or limit the progress of leishmaniasis. | ||
| Keywords | ||
| miRNAs; cutaneous leishmaniasis; miRNA-155-5P; CXCL9; CXCL10 | ||
|
Statistics Article View: 213 |
||
